BTIG Upgrades Core Scientific to Buy as HPC Outlook Improves
BTIG upgraded Core Scientific to Buy with a $23 target, citing improved prospects after the CoreWeave merger rejection and strong demand for high-performance computing power.
BTIG upgraded Core Scientific to Buy with a $23 target, citing improved prospects after the CoreWeave merger rejection and strong demand for high-performance computing power.
Citi resumed coverage of CoreWeave with a Buy rating and a $135 price target, citing strong demand despite short-term supply and capacity challenges.
Citizens analyst Greg Miller upgrades Core Scientific to Outperform, citing strong growth, HPC demand, and strategic focus after CoreWeave deal setback.
Oracle stock drops 11% after missing revenue targets despite massive AI investments. Cloud sales lag expectations while capital spending jumps to $50B, raising investor concerns about AI profitability timeline.
CoreWeave (CRWV) shares fell as the AI cloud-computing company plans to raise $2 billion through convertible notes, with part of the proceeds used to protect shareholders from stock dilution.
Dell boosts AI server shipment guidance to $25B as Q3 orders hit record $12.3B. Company raises full-year revenue outlook to $111.7B on strong data center demand.